Genetic tests for cancer can run thousands of dollars, but Color Genomics plans to change that: it's offering testing for the cancer risk variants BRCA1 and BRCA2 — as well as 17 others — for $249, ...

An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...

When the Human Genome Project concluded 21 years ago, it opened the door for genetic testing and a promise for lifesaving screenings and personalized medicine. An innovation that serves as a key ...

Color, a population genomics and healthcare technology company that counts Apple, Verily and, most recently, Sioux Falls, S.D.-based Sanford Health among its partners, has closed a $75 million funding ...

When a patient has an inherited cancer-associated gene, it is desirable — but not easy — to have other family members tested. In the United States, the difficulty primarily stems from privacy ...

In this interview, Chris Roberts of Aventa Genomics highlights the groundbreaking Aventa FusionPlus test, detailing its superior ability to detect gene fusions in cancer diagnostics and its pivotal ...